Search

everythinglearnresearchcommunity

for

Search:↓

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Senescent alopecia is a type of hair loss that occurs after age 50, not caused by genetics, and involves a gradual thinning of hair without significant inflammation.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Understanding the science of skin stretching is crucial for safe and effective hair replacement techniques.

Dr. Walter P. Unger believes lasers could eventually be important in hair transplantation for achieving natural-looking results, despite current limitations.

Some breast cancer chemotherapy can cause permanent hair loss.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Optical Coherence Tomography has potential in diagnosing hair loss and monitoring blood clotting, and could be improved for deeper tissue observation and better hair loss understanding.

Hair transplantation in East Asians needs special techniques to ensure natural results and prevent complications due to their unique hair and scalp characteristics.

Adenosine complex helps increase hair thickness and density in hair loss.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Finasteride improves hair loss in women with hyperandrogenism.

Bleaching hair removes its protective top layer and exposes more hydrophilic groups, changing its chemical surface and affecting how it interacts with products.

Amla oil may help treat hair loss.

New drug shows promise for better hair growth in baldness treatment.

Fine wool sheep have more genes for wool quality, while coarse wool sheep have more for skin and muscle traits.

Dupilumab for skin problems might reactivate hair loss in some patients.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Eyebrow reconstruction using hair follicle grafts was successful in a man with a benign hereditary disorder affecting his eyebrows.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

The authors' 10-year experience shows that a personalized approach to hair restoration surgery, using various techniques, leads to natural results and high patient satisfaction.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

The document concludes that follicular unit transplantation offers more natural results and better graft survival than older hair transplant methods.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.